UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients
Findings A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, ...
Tag: Oncology
,_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells")
ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells
A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, "ABT199/venetoclax synergism with thiotepa enhances ...
Overdosing on chemo: A common gene test could save hundreds of lives each year
One January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she ...
Study shows AI tool's high accuracy in answering genetic counseling questions
An artificial intelligence tool correctly answered 83 percent of common genetic counseling questions, including those about genetic testing and genetic ...
Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth
In a recent report published in Nature Medicine, researchers presented the initial results of recurrent glioblastoma (rGBM) patients treated with ...
UK lags in cancer treatment compared to other countries
People in the UK were treated with chemotherapy and radiotherapy less often than in comparable countries and faced long waits ...
UMSOM wins $3.5 million BARDA contract to develop animals models for radiation research
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected ...
Study reveals over 134,000 missed cancer diagnoses in the U.S. during COVID-19 pandemic
Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to ...
Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing
In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect ...
IPIAD augments standard therapy for pancreatic ductal adenocarcinoma
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added ...
POPULAR NEWS
